Hartmut Eickhoff, GSI 1 Developments in Hadrontherapy -the role of Basic Research Institutes H. Eickhoff GSI/Darmstadt.

Slides:



Advertisements
Similar presentations
Heavy Ion Cancer Therapy
Advertisements

MedAustron – Austrian Hadron Therapy Centre
Esteban Fabián Boggio 1 Lucas Provenzano 2 Sara Gonzalez 2,3 Sara Gonzalez 2,3 Juan Manuel Longhino 1 1 Bariloche Atomic Center, Atomic Energy National.
Experience, Expertise and a Commitment to Excellence™
Alexander Klyachko, IU Cyclotron, PTCOG51, Seoul, South Korea, May 17-19, 2012 A.V. Klyachko 1, D.F. Nichiporov 1, L. Coutinho 2, C.-W. Cheng 2, 3, M.
The TrueBeam System ™ Clinic Name Presenter’s name Clinic location
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Study of the fragmentation of Carbon ions for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck.
1 Bragg Curve  Protons and Carbon. 2 Application of Range  The localized energy deposition of heavy charged particles can be useful therapeutically.
Design and test of a high-speed beam monitor for hardon therapy H. Pernegger on behalf of Erich Griesmayer Fachhochschule Wr. Neustadt/Fotec Austria (H.
BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme PAMELA: Concepts Particle Accelerator for MEdicaL Applications K.Peach(JAI,
HIAT 2009, 9 th June, Venice 1 DESIGN STUDY OF MEDICAL CYCLOTRON SCENT300 Mario Maggiore on behalf of R&D Accelerator team Laboratori Nazionali del Sud.
Diagnostics for Medical Accelerators
Heavy Ion Tumor Therapy
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
The Skandion clinic, plans for the use of particle beams for radiation therapy in Sweden presented by Erik Grusell, medical radiation physicist Dept of.
FFAG Fixed Field Alternating Gradient synchrotrons, FFAGs, combine some of the main advantages of both cyclotrons and synchrotrons:  Fixed magnetic field.
Научно-практический центр протонной лучевой терапии и радиохирургии (Москва-Дубна) A SYSTEM FOR MEASUREMENT OF A THERAPEUTIC PROTON BEAM DOSE DISTRIBUTION.
A Laser Afternoon: Introduction Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin.
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
First Year Workshop 2014 Miriam Lafiandra
MedAustron Dr. Peter Urschütz, EBG MedAustron GmbH
24 September 2008 ENLIGHT, ESF Workshop-Oxford European Network for Light Ion Therapy ENLIGHT Manjit Dosanjh ENLIGHT Coordinator & CERN.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
Institute for Advanced Radiation Oncology
AAC February 4-6, 2003 Protons on Target Ioanis Kourbanis MI/Beams.
Cancer Therapy and Imaging Cancer Therapy and Imaging Rob Edgecock STFC Rutherford Appleton Laboratory.
CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.
Michael GalonskaWAO ´12, August Five years of operation at HIT Daily Performance Check & Beam Time Statistics M. Galonska, S. Scheloske, R. Cee,
JAI-Diamond Joint Seminar 07/06/20071 Development of Non-Scaling FFAG : EMMA & PAMELA Takeichiro Yokoi J. Adams Institute Oxford University.
FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a wide variety of applications Cancer Therapy and UK Activities.
Physics of carbon ions and principles of beam scanning G. Kraft Biophysik, GSI, Darmstadt, Germany PTCOG43 Educational Satellite Meeting: Principles of.
USE OF GEANT4 CODE FOR VALIDATION OF RADIOBIOLOGICAL PARAMETERS OBTAINED AFTER PROTON AND CARBON IRRADIATIONS OF MELANOMA CELLS Ivan Petrović 1, Giuseppe.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
New Gantry Idea for H + /C 6+ Therapy G H Rees, ASTeC, RAL 4 th September, 2008.
Cern.ch/knowledgetransfer. Knowledge Transfer | Accelerating Innovation BE-KT Innovation Day,
ENLIGHT,12/2/20021 Health and Science, can CERN contribute? The Mission of CERN (1954): “The Organization shall provide for collaboration among European.
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
FrontierScience G.P.1 MATRIX an innovative Pixel Ionization Chamber for Online Monitoring of Hadrontherapy Treatments Giuseppe Pittà.
Odds and Ends on Gantries Rob Edgecock & Akram Kahn Neither of us knew much about gantries ~1 week ago Neither of us know much about gantries now Will.
T. Fleck, GSI, Darmstadt, Germany ICALEPCS Status of the Control System for HICAT at an advanced stage of Commissioning Functions, Restrictions.
Flair development for the MC TPS Wioletta Kozłowska CERN / Medical University of Vienna.
Development of a superconducting rotating-gantry for carbon therapy
The Australian Hadron Therapy and Research Facility.
Varian Medical Systems
HADRONTHERAPY IN ROMANIA NICOLAE IOAN VERGA M.D., Ph.D., D.Sc. “CAROL DAVILA” UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN SOCIETY OF HADRONTHERAPY BUCHAREST,
Koichi MurakamiGeant4 Physics Verification and Validation (17-19/Jul./2006) 1 Results from the recent carbon test beam at HIMAC Koichi Murakami Statoru.
Beam dynamics and linac optics studies for medical proton accelerators
Research and Practical Conference “Accelerators and Radiation technologies for the Futures of Russia” September 2012, Saint-Petersburg Proton Radiation.
April 17, Dejan TrbojevicFFAG07 -Non-Scaling FFAG gantries1 Non-Scaling FFAG Gantries Introduction: Motives: The most challenging problem in the carbon/proton.
0 Ion Beam Facilities at KOMAC Chan Young Lee on behalf of KOMAC Chan Young Lee on behalf of KOMAC ICABU2014, November 12~14,
RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, Maggio 2016.
Plans and Activities at CERN
Radiological Protection in Ion Beam Radiotherapy
Present and possible future schemes for hadron therapy linacs Alberto Degiovanni for the ADAM team HG2017 Workshop , Valencia.
Progress in the Application
BEAT_PRO Beam Tailoring and procedures optimization for clinical bnct
A.Sidorin, on behalf of the team PP PAC, JINR, Dubna, 16 January 2017
Accelerator layout > 1000 components (almost 300 magnets and power converters, 153 beam diagnostic devices, about 400m of vacuum pipes, a not neglectable.
Diagnostics of FRIBs beam transport line
Linac Commissioning Overview
A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.
Kuanjun Fan Institute of applied electromagnetic engineering
Design of a PET-isotope-based hadron therapy facility
M. D. Anderson Cancer Center Houston, TX
Advanced Research Electron Accelerator Laboratory
Physics Design on Injector I
Multiphysics Simulation Story: MRI Tumor-Tracked Cancer Treatment
Presentation transcript:

Hartmut Eickhoff, GSI 1 Developments in Hadrontherapy -the role of Basic Research Institutes H. Eickhoff GSI/Darmstadt

Hartmut Eickhoff, GSI 2 Contents 1.General aspects 2.Treatment principles and modalities 3.The GSI Therapy pilot project 4.The HIT project 5.future developments 6.Summary /conclusions

Hartmut Eickhoff, GSI 3 Hadrontherapy-Facilities Location Distribution of Hadrontherapy- facilities (p, C-ions)

Hartmut Eickhoff, GSI Ref.: Particle Therapy Cooerative Group (PTCOG), 2013 Hadrontherapy-Facilities

Hartmut Eickhoff, GSI Total treated patients ( ): about (Ref.:PTCOG) Hadrontherapy-Facilities Treated patients Hadrontherapy-Facilities Treated patients

Hartmut Eickhoff, GSI 6 - Early facilities (until 1990) had been mostly installed in basic research institutes (e.g. LBL, PSI, Dubna,..) and operated by them - Also for hospital based facilities research institutes play a significant role, e.g.: -accelerator development of FERMILAB for Loma-Linda -Proton-Ion-Medical-Machine-Study group (coordinated by CERN) -Accelerator related support of CERN for CNAO and MEDAUSTRON -Activities of GSI at HIT and CNAO General aspects

Hartmut Eickhoff, GSI 7 n Radiotherapy principle n Destruction of a localised cancer via irradiation with ionising radiation n and maintaining of dose in the surrounding healthy tissue low, in tolerable limits n Requirements to radiation source n Adequate dose depth profile of radiation n Geometrical flexibility of radiation direction and beam size Treatment principles and modalities

Hartmut Eickhoff, GSI 8 n Sequential treatment n Irradiation with different energies => slicing of the tumor in isoenergetic planes n Intensity variation per plane to get flat dose distribution Treatment principles and modalities Spread-out Braggpeak (SOBP)

Hartmut Eickhoff, GSI 9 n Treatment with C-Ions n Better ratio of dose inside/outside tumor volume (larger RBE-factor) n Only small enhancement of beam diameter vs. penetration depth -> better control for deep seated tumors n Online dose-control possible (Positron Emission Tomograph) n Treatment with protons n Large medical data base for proton treatments available Treatment principles and modalities comparison, p, ions

Hartmut Eickhoff, GSI 10 Treatment principles and modalities ‚passive‘ treatment modality - constant beam properties (accelerator) - mechanical devices for adequate manipulations of beam properties - fragmentations - not optimal tumour adaption

Hartmut Eickhoff, GSI 11 n Intensity-controlled Rasterscan-method Treatment principles and modalities ‚active‘ treatment modality

Hartmut Eickhoff, GSI 12 The GSI-Therapy Pilot project (GSI, DKFZ, FZD) Goals Technical developments of a new treatment modality (the ‚intensity controlled rasterscan method‘) Development of new diagnostic tools (e.g. ‚on- line‘-PET) Patient treatments with carbon ions; evaluation of the medical attributes / properties

Hartmut Eickhoff, GSI 13 The GSI-Therapy Pilot project (GSI-facility) The GSI-accelerator facility (with experimental areas)

Hartmut Eickhoff, GSI 14 The GSI Therapy pilot project Overview of GSI main-research topics

Hartmut Eickhoff, GSI The GSI-Therapy Pilot project additional hardware installations

Hartmut Eickhoff, GSI 16 Parameter (GSI-project): 255 energy-steps ( MeV/u) 15 intensity-steps ( ions/puls) 7 beamwidths ( 4-10 mm FWHM) The GSI-Therapy Pilot project Rasterscan requirements (1)

Hartmut Eickhoff, GSI 17 n Beam-Position feed-back n Intensity-distribution (isoenergy-slice) Feed-back Scanner /MWPC with feedback without feedback Preirradiation has to be considered _> highly inhomogenious distribution The GSI-Therapy Pilot project Rasterscan requirements (2)

Hartmut Eickhoff, GSI Challenges (accelerator operation system) : More than beam parameter settings have to be provided with high accuracy within second-range Realization-concept: Generation of a set value-library for the accelerator systems for all requested beam parameters, that provides reproducable beam accuracy and can be activated from the treatment operation system The GSI Therapy pilot project Operating aspects

Hartmut Eickhoff, GSI 19 The GSI Therapy pilot project beam position accuracy (<1 mm) For all requested beam energies Over longer times

Hartmut Eickhoff, GSI Th. Haberer, Heidelberg Ion Therapy Center Scanning-ready pencil beam library ( combinations): 253 energies (1mm range steps) x 7 spot sizes x 15 intensity steps Rasterscan method incl. approved controls and safety Beammonitors follow the scanned beams (v <= 40 m/s) in real-time In-beam Positron Emission Tomography QA system Prototype of the scanning ion gantry Biological interactionmodel (LEM) based on 25 years of radiobiological research Physical beam transportmodel Planningsystem TRiP The GSI Therapy pilot project Key-developments at GSI

Hartmut Eickhoff, GSI -The extraordinary requirements for the accelerator system could be realized and successfully demonstrated; -The irradiation by means of C-ions and the rasterscan modality was established; -Reliable patient-treatments and the medical advantages could be successfully demonstrated for more than 450 Patienten (about fractions); -The path to a dedicated, clinic-based facility with the rasterscan treatment modality was shown. The GSI Therapy pilot project Results

Hartmut Eickhoff, GSI 22 The Heidelberg project HIT Requirements (1) General requirements for a hospital based Ion-Therapy Facility with rasterscan-method n High availability -> ‘conservative’, testet technology n Cost effectivness design (investment- and operation costs) n Easy to handle (‘one knob’-machine) Special requirements for the rasterscan modality n large variety of set parameters (energy, focus, intensity) n Fast change of set-parameters (sec-range) n Reliable, tested complete set-parameter library n Safety requests (correct parameters), spill-interruption channels

Hartmut Eickhoff, GSI 23 n Low LET (proton, helium) and high LET (carbon and oxygen) treatment n Ion penetration depth of 20 – 300 mm => Ion energy range of 50 – 430 MeV/u n Rasterscan method => FWHM of beam: 4 – 10 mm in both planes => Beam intensity: 1·10 6 – 4·10 10 ions/spill => Extraction time: 1 – 10 s n Treatment of 1000 patients per year in hospital environment with about 15 fractions each => total of irradiations per year => three treatment areas n One isocentric gantry The Heidelberg project HIT Requirements (2)

Hartmut Eickhoff, GSI 24 n Subproject Accelerator n No general contractor found -> subsystems ordered n Tasks of GSI (by contracts): n technical planning (specs of accelerator, treatment-technique) n Technical consultant during tender n Technical supervisor of firms n Assembly of (most of the) components n Training of operation team n Commissioning to ‘treatment beam quality’ The Heidelberg project HIT Role of GSI

Hartmut Eickhoff, GSI 25 n Accelerator sections n Two ECR sources n RFQ n IH drift tube linac n Synchrotron n Extraction via RF knock out n Two areas for horizontal treatment n One isocentric Gantry n One quality assurance place 1. patient-treatment: 2. half 2009 The Heidelberg project HIT Facility layout

Hartmut Eickhoff, GSI 26 Ion-source-sectionLinac-section The Heidelberg project HIT Realization (1)

Hartmut Eickhoff, GSI 27 synchrotron treatment-room The Heidelberg project HIT Realization (2)

Hartmut Eickhoff, GSI 28 n First Light ion Gantry n weight: 600 to n 13 m diameter n beam position accuracy at isocenter : 0.5 mm n Integration of hor. and vert. scannermagnets Ref.: MT Aerospace The Heidelberg project HIT Isocentric Gantry

Hartmut Eickhoff, GSI 29 The Heidelberg project HIT Isocentric Gantry part of the Gantry structure

Hartmut Eickhoff, GSI 30 Future developments Major development goals - Extension of the treatment application (e. g. treatment of ‚moving targets‘ - Optimization of the operation- /treatment time - Reduction investment and operation costs (e.g. reduction of size, application of sc-systems)

Hartmut Eickhoff, GSI 31 magnetic scanner system PMMA wedge system suitable motion tracking system dynamic treatment plan staticmoving, non-compensated moving, compensated  real-time, highest precision, passive energy variation Future developments Treatment of moving targets

Hartmut Eickhoff, GSI 32 Future developments reduction of treatment time (fast) active energy-variation within a synchrotron cycle at HIMAC (Noda, Erice, 2009)

Hartmut Eickhoff, GSI 33 Laser accelaration Small accelerator structures due to large acceleration voltage Problems: - Continuous energy- spectrum -Rel. low energies (few MeV) - repetition rate -Reliability, reproducability -Long term development Creation of ‚monoenergetic beam‘ Future developments Laser acceleration

Hartmut Eickhoff, GSI Research Institutes (and existing Hadrontherapy-Facilities)  First steps of new concepts (including feasibility studies) and early stages of developments are often performed by research institutes (e.g. feasibility of rasterscan treatment modality, laser acceleration,..)  Existing hospital based Hadrontherapy-Facilities also push technological developments to optimize the treatment conditions  (e. g. NIRS, beam extraction procedures, …  CNAO, field regulation…,  HIT, intensity feed-back,…) Summary/ conclusion (1)

Hartmut Eickhoff, GSI Industries  Industrial firms are very competent to develop technical solutions for optimized cost efficiency  There are several industrial firms to provide technical subsystems for medical accelerators (magnets, RF-systems,..)  There are only a few industrial firms that act as general contractors for treatment facilities (mostly cyclotron based p- facilities). -> Information exchange / collaboration to institutes, and industries in an early project stage desirable Summary / conclusion (2)

Hartmut Eickhoff, GSI 36 Thanks for your attention